Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506
To reduce in-stent restenosis rates, we developed a novel drug-eluting covered stent with a microporous elastometric covered film, in which its luminal surface was flat and immobilized with heparin for anticoagulation and its outer surface immobilized with FK506 to prevent neointimal hyperplasia. One month after implantation into the bilateral common carotid arteries, all stented arteries were patent and the luminal surfaces were fully covered with a confluent of endothelial cells irrespective of the drug immobilization. In the control group, which consisted of covered stents without drug immobilization, intensive inflammatory cells adjacent to the stents and neointimal hyperplasia, indicating vascular injury, were observed. In contrast, in the developed drug-eluting stents, only a few inflammatory cells around the stent strut and covered film were observed, and there was no significant neointimal thickening.
- OSTI ID:
- 20650562
- Journal Information:
- Cardiovascular Radiation Medicine, Vol. 4, Issue 2; Other Information: DOI: 10.1016/S1522-1865(03)00143-4; PII: S1522186503001434; Copyright (c) 2003 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 1522-1865
- Country of Publication:
- United States
- Language:
- English
Similar Records
Embolization of experimental aneurysms using a heparin-loaded stent graft with micropores
Effect on Intimal Hyperplasia of Dexamethasone Released from Coated Metal Stents Compared with Non-Coated Stents in Canine Femoral Arteries